Transcranial Photobiomodulation with Patients with Parkinson's Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Parkinson\'s disease (PD) is the second most common neurodegenerative disorder after Alzheimer\'s disease. It is a progressive and disabling disease with significative impact on quality of life. Since it has no cure, available treatment is targeted to improve the symptoms due to a lack of dopamine in the central nervous system. The aim of the study was to see how transcranial photobiomodulation (tPBM) helped patients with Parkinson\'s disease.
Epistemonikos ID: c6e9447135e078e935b76abc86c0f8d60f288a72
First added on: Jan 01, 2025